- Investing Ideas
- /
- Vietnamese Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Vietnamese Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
2
0 new
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
2 companies
Traphaco
Market Cap: ₫2.8t
Produces and trades in pharmaceutical products, chemicals, and medical supplies and equipment in Vietnam.
TRA
₫68,000.00
7D
0%
1Y
-12.4%
Phong Phu Pharmaceutical
Market Cap: ₫179.5b
Engages in the production, sale, and distribution of medicines primarily in Vietnam.
PPP
₫20,400.00
7D
-1.9%
1Y
18.6%